Related Experiment Videos
[Laser angioplasty and recanalization]
1Abteilung für Kardiologie, Zentrum für Innere Medizin, Universität-GHS Essen.
Herz
|March 4, 1998
Summary
Percutaneous transluminal coronary balloon angioplasty (PTCA) has limitations. Excimer laser angioplasty offers plaque ablation for coronary artery disease, showing promise for in-stent restenosis and total occlusions.
Area of Science:
- Cardiovascular Interventions
- Medical Technology
- Laser Applications in Medicine
Context:
- Percutaneous transluminal coronary balloon angioplasty (PTCA) is a primary treatment for coronary artery disease, but its effectiveness is limited by acute complications and long-term restenosis.
- Alternative plaque ablation techniques, including various forms of laser angioplasty, have been developed to overcome PTCA's limitations.
Purpose:
- To review the development and clinical application of 308 nm XeCl excimer laser angioplasty for coronary artery disease.
- To evaluate the efficacy and safety of excimer laser angioplasty in treating specific lesion types, including in-stent restenosis and chronic total occlusions.
Summary:
- 308 nm XeCl excimer laser angioplasty ablates plaque via gas bubble expansion but has shown comparable results to PTCA for diffuse/long lesions and total occlusions.
- Recent investigations focus on its use for in-stent restenosis, with initial results indicating practicability and safety.
- Laser guidewires demonstrate improved recanalization rates for chronic total occlusions compared to mechanical wires.
Impact:
- Excimer laser angioplasty, particularly with advancements in laser guidewires, presents a potential improvement over traditional PTCA for specific complex coronary lesions.
- Ongoing research and technical refinements aim to enhance the safety, predictability, and effectiveness of laser-based coronary interventions.